In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion

12-Nov-2020

Merck grew significantly in the third quarter. In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion. The increase was primarily due to double-digit percentage organic growth in the Life Science business sector and acquisition-related increases in the ...

more

Additional OLED sublimation units will help meet customer demand in the growing OLED market of Asia

29-Oct-2020

Merck announced a € 20 million expansion of its OLED (organic light-emitting diode) manufacturing capacity at its sites in Pyeongtaek, Korea and Shanghai, China. Additional sublimation units will be built to help meet customer demand in the growing OLED market. With the investment, Merck will ...

more

Two internationally experienced managers to join Executive Board

30-Sep-2020

Stefan Oschmann will hand over the Chair of the Executive Board of Merck to Belén Garijo in 2021. The Board of Partners of E.MerckKG has appointed Garijo as new Chair of the Executive Board and CEO of Merck effective May 1, 2021. She is currently Vice Chair of the Executive Board and Deputy CEO ...

more

From today’s perspective targeted smaller to medium-sized acquisitions after 2022 more likely than major transformative deals

17-Sep-2020

Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the period ...

more

Healthcare and Performance Materials more strongly affected by the Covid-19 pandemic than Life Science

06-Aug-2020

Merck registered the effects of the Covid-19 pandemic in all business sectors in the second quarter. Healthcare and Performance Materials were affected most strongly. In comparison with the year-earlier quarter, Group sales increased by 3.7% to € 4.1 billion. EBITDA pre, the Group’s most ...

more

Belén Garijo appointed Vice Chairman of the Executive Board and Deputy CEO

16-Jul-2020

The Board of Partners of E.MerckKG appointed Belén Garijo as Vice Chairman of the Executive Board and Deputy CEO of Merck KGaA. She will maintain her current Executive Board responsibilities. “The appointment of Belén Garijo as Vice Chairman of the Executive Board and Deputy CEO recognizes her ...

more

Startup from Merck Innovation Lab in Israel Markets First Predictive Maintenance Sensors

25-Jun-2020

Merck announced the first commercial product from Feelit, based in Haifa, Israel. Feelit is an Industry 4.0 startup that was part of the Merck PMatX innovation lab for next-generation electronics in Israel. RetroFeel™, the company’s first product, combines a wireless edge device and a printed ...

more

Neuromorphic computing considered as key enabler of next-generation artificial intelligence

07-May-2020

Merck announced its investment in SynSense (formerly known as aiCTX), a neuromorphic computing startup based in China and Switzerland. The startup’s AI (artificial intelligence) processors and sensors provide an unprecedented combination of ultra-low power consumption and low latency for a broad ...

more

06-Mar-2020

Merck met all its financial targets and thus grew profitably in fiscal 2019. At the same time, Merck also made significant progress in executing its strategic agenda. “We delivered on our promise and achieved growth for all our key performance indicators, namely net sales, EBITDA pre and EPS pre. ...

more

15-Nov-2019

Merck generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019. EBITDA pre increased even more strongly than net sales in the three-month period from July to September. Following the closing of the Versum Materials (Versum) ...

more